Defining the Roles of Inflammatory Bowel Disease Clinical Pharmacists in the United States: A Systematic Review and National RAND/UCLA Consensus.

Background: Given the complexity of inflammatory bowel disease (IBD) care, utilization of multidisciplinary teams is recommended to optimize outcomes. There is a growing recognition that clinical pharmacists should be an integral part of this care model. We sought to define the roles of IBD clinical pharmacists in the United States.

Ozanimod: A First-in-Class Sphingosine 1-Phosphate Receptor Modulator for the Treatment of Ulcerative Colitis.

Objective: To review the pharmacological and clinical profile of ozanimod in the treatment of ulcerative colitis (UC).

Data Sources: A PubMed search was conducted from inception to July 2021 using the keywords , , and . Information was also extracted from published abstracts and the package insert.

Development of a screening tool to identify patients likely to benefit from clinical pharmacist review in a home-based primary care population.

Objective: To create a novel screening tool that identified patients who were most likely to benefit from pharmacist in-home medication reviews.

Design: Single-center, retrospective study.

Setting And Participants: A total of 25 homebound patients in Forsyth County, NC, aged 60 years or older with physical or cognitive impairments and enrolled in home-based primary care or transitional and supportive care programs participated in the study.